More on NVNO
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $6.73 |
|
|||
| Open | $6.73 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $6.73 | ||||
| Day Low | $6.73 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 8 | ||||
- enVVeno Medical to Showcase the enVVe System at 38th Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium
- enVVeno Medical (NVNO) Misses Q3 EPS by 302c
- enVVeno Medical Reports Third Quarter 2026 Financial Results and Prepares to Treat First Patients in FDA-Approved TAVVE Pivotal Study
- Form DEFA14A enVVeno Medical Corp
- Form DEF 14A enVVeno Medical Corp For: Dec 10
- Form 10-Q enVVeno Medical Corp For: Sep 30
- enVVeno Medical Releases New Episode of "WTF" Video Series Featuring CEO Rob Berman
- enVVeno Medical's First-in-Class enVVe System to Be Featured at The VEINS 2026 Innovation Summit as Company Advances Toward U.S. Pivotal Trial
- enVVeno Medical CEO Rob Berman Goes Direct to Investors with New "WTF" Video Series
- Form SCHEDULE 13D/A enVVeno Medical Corp Filed by: Braeden Lichti
Entities mentioned with NVNO
- FDA | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- S3 | View Related Stories »
- Kingdon Capital Management | View Related Stories »
- Show More...
